Disease burden of mild asthma in China

Disease burden of mild asthma in China AbbreviationsACTAsthma Control TestDSPDisease Specific ProgramEDemergency departmentFEV1forced expiratory volume in 1 sGINAGlobal Initiative for AsthmaICSinhaled corticosteroidLTRAleukotriene receptor antagonistSOBshortness of breathTCMtraditional Chinese medicineINTRODUCTIONAsthma is a common, chronic respiratory disease estimated to affect 1.0–18.0% of the population depending on the country. The 2002 prevalence estimates of 3.0–6.0% for Asia‐Pacific nations are lower compared with Western countries, although prevalence in Asia appears to be on the rise. This increase has been attributed to environmental exposures, with children and the elderly at highest risk.Thirty million people in China are affected by asthma. A household survey of more than 180 000 individuals 14 years or older residing in eight provinces of China revealed an overall asthma prevalence of 1.2%, while other studies report a prevalence of 1.1% across all age groups. Prevalence is higher in urban areas at 1.4% versus 0.9% for rural locations. Crucially and consistent with trends in other Asia‐Pacific countries, asthma prevalence in China appears to be increasing.Treatment goals include optimal symptom control, maintenance of normal activity levels and reductions in exacerbations and fixed airflow limitations, with minimal side effects. Pharmacological treatment options are guided by severity. Mild asthma is asthma that is well controlled with Step 1 or Step 2 treatment http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Respirology Wiley

Disease burden of mild asthma in China

Loading next page...
 
/lp/wiley/disease-burden-of-mild-asthma-in-china-Z10GQu3KU0
Publisher
Wiley Subscription Services, Inc., A Wiley Company
Copyright
© 2018 Asian Pacific Society of Respirology
ISSN
1323-7799
eISSN
1440-1843
D.O.I.
10.1111/resp.13189
Publisher site
See Article on Publisher Site

Abstract

AbbreviationsACTAsthma Control TestDSPDisease Specific ProgramEDemergency departmentFEV1forced expiratory volume in 1 sGINAGlobal Initiative for AsthmaICSinhaled corticosteroidLTRAleukotriene receptor antagonistSOBshortness of breathTCMtraditional Chinese medicineINTRODUCTIONAsthma is a common, chronic respiratory disease estimated to affect 1.0–18.0% of the population depending on the country. The 2002 prevalence estimates of 3.0–6.0% for Asia‐Pacific nations are lower compared with Western countries, although prevalence in Asia appears to be on the rise. This increase has been attributed to environmental exposures, with children and the elderly at highest risk.Thirty million people in China are affected by asthma. A household survey of more than 180 000 individuals 14 years or older residing in eight provinces of China revealed an overall asthma prevalence of 1.2%, while other studies report a prevalence of 1.1% across all age groups. Prevalence is higher in urban areas at 1.4% versus 0.9% for rural locations. Crucially and consistent with trends in other Asia‐Pacific countries, asthma prevalence in China appears to be increasing.Treatment goals include optimal symptom control, maintenance of normal activity levels and reductions in exacerbations and fixed airflow limitations, with minimal side effects. Pharmacological treatment options are guided by severity. Mild asthma is asthma that is well controlled with Step 1 or Step 2 treatment

Journal

RespirologyWiley

Published: Jan 1, 2018

Keywords: ; ; ; ;

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial